Subheading · Section VI
3002.13: Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
- FreeUK
- FreeEU
- 50%Türkiye
- FreeUSA
- US$4.9bnWorld trade in 2024
3002.13 is a six-digit subheading of heading 3002, human blood; animal blood prepared for therapeutic, prophylactic or diagnostic…, chapter 30.
Subheading 3002.13 is a single line in the UK Global Tariff, where the duty is duty-free.
The EU Combined Nomenclature has one tariff line for subheading 3002.13; the duty is duty-free.
Subheading 3002.13 is a single line in the Turkish Customs Tariff Schedule, where the statutory rate is 50%.
The Harmonized Tariff Schedule of the United States has one tariff line for subheading 3002.13; the duty is duty-free.
World trade in these goods reached US$4.9bn in 2024, down 27.4% on 2023.
The United States was the largest exporter with 16.9% of the total, ahead of Ireland.
Switzerland imported the most (US$673.5m).
The United Kingdom ranked 13th among 75 exporters with US$80.6m; its largest buyer was the United States.
The United Kingdom imported US$30m, most of it from the Netherlands.
Duty rates compared
UK Free Third-country duty 1 tariff line 
EU Free Third-country duty 1 tariff line 
Türkiye 50% Statutory rate (Law 474) 1 tariff line 
USA Free General (MFN) 1 tariff line The Turkish schedule prints the statutory rate set under Customs Law 474. The rate applied at import is laid down in the Import Regime Decision and can be lower, or different by country of origin.
UK Global Tariff
UK lines →- 3002 13 00 00 Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale Free
EU Combined Nomenclature
EU lines →- 3002 13 00 Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale Free—
Turkish Customs Tariff Schedule
Türkiye lines →This line has no official text in this language; it is shown in the language of its tariff.
- 3002.13.00.00.00 Dozlandırılmamış veya perakende satışa uygun şekilde ambalajlanmamış/hazırlanmamış, karışım olmayan bağışıklık ürünleri 50%
Harmonized Tariff Schedule of the United States
USA lines →- 3002.13.00 Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale Free
- 3002.13.00.10 Monoclonal antibodies kg
- 3002.13.00.90 Other kg
World trade in 2024
Trade value (US$) no reported trade < US$1.6mUS$1.6m+US$61.5m+US$273.6m+> US$613.4m
Exports: 75
- United States: US$821.5m
- Ireland: US$613.4m
- Türkiye: US$582m
- Switzerland: US$438.8m
- Singapore: US$407.1m
- Belgium: US$298.4m
- Germany: US$273.6m
- South Korea: US$267.9m
- Japan: US$169.3m
- France: US$167.3m
- Austria: US$138.3m
- India: US$86.1m
- United Kingdom: US$80.6m
- Netherlands: US$74m
- Sweden: US$71.6m
- Hungary: US$67.5m
- Denmark: US$61.5m
- Poland: US$51.7m
- Lithuania: US$36.7m
- Spain: US$34.5m
- China: US$26.2m
- Russia: US$22.2m
- Slovenia: US$19.9m
- Costa Rica: US$14m
- Israel: US$8.2m
- Iran: US$7.3m
- Taiwan: US$6m
- Czechia: US$5.5m
- Italy: US$4m
- Canada: US$3.6m
- Australia: US$2.4m
- Argentina: US$1.7m
- Hong Kong SAR China: US$1.6m
- Romania: US$1.5m
- Slovakia: US$1m
- Finland: US$788.1k
- New Zealand: US$383k
- South Africa: US$281k
- Jordan: US$259.1k
- Belarus: US$68.3k
- Saudi Arabia: US$34.4k
- Chile: US$28.5k
- Iceland: US$25.2k
- Brazil: US$24.8k
- Kazakhstan: US$24k
- Colombia: US$19k
- Cuba: US$11.3k
- Ukraine: US$10.1k
- Ghana: US$6.7k
- Norway: US$5.7k
- Lebanon: US$5.6k
- Estonia: US$5k
- Peru: US$3.1k
- Ecuador: US$1.2k
- Bulgaria: US$400
- Nepal: US$400
- Portugal: US$300
- Croatia: US$200
- Luxembourg: US$200
- Malaysia: US$200
Trade value (US$) no reported trade < US$474.3kUS$474.3k+US$5.6m+US$90.8m+> US$423.8m
Imports: 133
- Switzerland: US$673.5m
- Germany: US$547.1m
- France: US$473.7m
- Ireland: US$423.8m
- Italy: US$359.9m
- United States: US$323.2m
- Hungary: US$316.6m
- Türkiye: US$306.4m
- South Korea: US$278.9m
- Austria: US$229.5m
- Slovenia: US$180.1m
- Japan: US$156.7m
- Netherlands: US$93.9m
- Sweden: US$90.8m
- Croatia: US$52.5m
- China: US$42.5m
- Israel: US$35.7m
- Belgium: US$33.7m
- United Kingdom: US$30m
- Armenia: US$24.6m
- Brazil: US$21.8m
- Kazakhstan: US$18.2m
- Denmark: US$13.8m
- Czechia: US$11.8m
- Australia: US$10.1m
- India: US$8.7m
- Canada: US$8.5m
- Russia: US$8.2m
- Singapore: US$7.3m
- Paraguay: US$6.6m
- Dominican Republic: US$6.5m
- Saudi Arabia: US$5.7m
- Finland: US$5.6m
- Hong Kong SAR China: US$5.1m
- Spain: US$4.8m
- Indonesia: US$4.7m
- Argentina: US$3.9m
- Chile: US$3.4m
- Taiwan: US$3m
- Ecuador: US$2.9m
- Poland: US$2.8m
- Mexico: US$2.4m
- Nicaragua: US$2.3m
- Greece: US$2.1m
- Guatemala: US$1.9m
- Colombia: US$1.7m
- Cayman Islands: US$1.4m
- Uruguay: US$1.4m
- Slovakia: US$1.3m
- Portugal: US$1.3m
- Lithuania: US$1.1m
- Vietnam: US$1.1m
- Kuwait: US$907.4k
- Malaysia: US$854.2k
- Honduras: US$777k
- Bangladesh: US$687.9k
- Aruba: US$654.9k
- Norway: US$642.9k
- Uzbekistan: US$634.4k
- Azerbaijan: US$615.2k
Top exporters
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | United States | US$821.5m | 16.9% |
| 2 |  Ireland | US$613.4m | 12.6% |
| 3 | Türkiye | US$582m | 12% |
| 4 |  Switzerland | US$438.8m | 9% |
| 5 |  Singapore | US$407.1m | 8.4% |
| 6 |  Belgium | US$298.4m | 6.1% |
| 7 |  Germany | US$273.6m | 5.6% |
| 8 |  South Korea | US$267.9m | 5.5% |
| 9 |  Japan | US$169.3m | 3.5% |
| 10 |  France | US$167.3m | 3.4% |
Top importers
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | Switzerland | US$673.5m | 13.8% |
| 2 | Germany | US$547.1m | 11.2% |
| 3 | France | US$473.7m | 9.7% |
| 4 | Ireland | US$423.8m | 8.7% |
| 5 |  Italy | US$359.9m | 7.4% |
| 6 | United States | US$323.2m | 6.6% |
| 7 |  Hungary | US$316.6m | 6.5% |
| 8 | Türkiye | US$306.4m | 6.3% |
| 9 | South Korea | US$278.9m | 5.7% |
| 10 |  Austria | US$229.5m | 4.7% |
Legal notes
Subheading notes
1. For the purposes of subheadings 300213 and 300214, the following are to be treated:
(a) as unmixed products, pure products, whether or not containing impurities;
(b) as products which have been mixed:
(1) the products mentioned in (a) above dissolved in water or in other solvents;
(2) the products mentioned in (a) and (b) (1) above with an added stabiliser necessary for their preservation or transport; and
(3) The products mentioned in (a), (b) (1) and (b) (2) above with any other additive.
2. Subheadings 300360 and 300460 cover medicaments containing artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or containing any of the following active principles, whether or not combined with other pharmaceutical active ingredients : amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN).
Questions and answers
What is the HS code for immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale?
Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale fall under HS subheading 3002.13, part of heading 3002, in section VI of the Harmonized System.
What is the import duty on immunological products, unmixed in the UK?
Under the UK Global Tariff, imports under 3002.13 from countries without a preferential agreement are free of duty. Preferential rates, anti-dumping duties and VAT are not included.
What is the import duty on immunological products, unmixed in the EU?
Under the EU Combined Nomenclature, imports under 3002.13 from countries without a preferential agreement are free of duty. Preferential rates, anti-dumping duties and VAT are not included.
Which country exports the most immunological products, unmixed?
The United States, with US$821.5m in 2024 (16.9% of world exports).